Cholecystitis
Conditions
Keywords
GB stone
Brief summary
529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria. They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.
Detailed description
529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria. They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.
Interventions
DRUGCefotetan
Cefotetan (as Disodium) 1 GM Injection before surgery
Sponsors
Chonbuk National University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
patients who have diagnosed -cholecystitis with / without GB stone, GB polyp
Exclusion criteria
1. Suspected cholangitis and GB cancer 2. CBD stone history 3. Preoperative administration of antibiotics within 7days. 4. Suspected pregnancy 5. Open conversion. 6. Patients refuse this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| surgical complication | 30days | surgical site infection |
Outcome results
None listed